Additive systems for use in protein PEGylation

Patent metadata

Field	Value
Publication number	US-10617765-B2
Application number	US-201615776923-A
Country	US
Kind code	B2
Filing date	Nov 22, 2016
Priority date	Nov 23, 2015
Publication date	Apr 14, 2020
Grant date	Apr 14, 2020

Abstract

The present disclosure provides an additive system for use in protein PEGylation. The additive system includes p-aminobenzoic hydrazide used either alone or in combination with aromatic amines, such as 3,5-diaminobenzoic acid, or with ammonium salts such as ammonium chloride or ammonium acetate. The disclosed additive combination provides several benefits including increased reaction rates, higher yields and reduction in the aminoxy-PEG equivalents required to complete the conjugation reaction. Typical reactions can be run by combining the additive or additive system with a solution of a protein and aminoxy-PEG reagent. The solution is adjusted to pH 4 and held at 20-25° C. without stirring until completion, typically within 24 hours.

First claim

We claim:

1. A process for obtaining PEGylated protein, said process comprising steps of:
(a) identifying a protein, PEG reagent and an additive system;
(b) solubilizing the protein followed by combining the protein with the PEG reagent in presence of the additive system,
(c) reacting the protein with the PEG reagent to form a ketoxime and obtain PEGylated protein,
wherein said additive system includes p-aminobenzoic hydrazide.

2. The process of claim 1 , wherein said protein carries a p-acetylphenylalanine residue.

3. The process of claim 1 , wherein the solubilized protein combined with the PEG reagent in presence of the additive system is maintained at a pH of about 4.

4. The process of claim 1 , wherein the solubilized protein combined with the PEG reagent in presence of the additive system is held at a temperature ranging from about 20° C. to about 25° C.

5. The process of claim 1 , wherein said additive system includes p-aminobenzoic hydrazide in combination with an aromatic amine, such as 3,5-diaminobenzoic acid, or an ammonium salt, such as ammonium acetate or ammonium chloride.

6. The process of claim 5 , wherein said additive system further includes ammonium chloride.

7. The process of claim 1 , wherein said PEG reagent is selected from a group comprising PEG-OA and other PEG derivatives with an aminoxy group.

8. The process of claim 2 , wherein said protein is Relaxin or FGF21.

Assignees

• Bristol Myers Squibb Co

Inventors

• Hickey Matthew R
• Ramirez Antonio

Classifications

• C07K14/50

  Fibroblast growth factor [FGF] · CPC title

• A61K47/60 Primary

  the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol · CPC title

• C07K1/1077 Primary

  by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids · CPC title

• C07K14/64

  Relaxins · CPC title